Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers

An update

Ophira Ginsburg, Parviz Ghadirian, Jan Lubinski, Cezary Cybulski, Henry T. Lynch, Susan Neuhausen, Charmaine Kim-Sing, Mark Robson, Susan Domchek, Claudine Isaacs, Jan Klijn, Susan Armel, William D. Foulkes, Nadine Tung, Pal Moller, Ping Sun, Steven A. Narod

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Among women with a mutation in BRCA1 or BRCA2, the risk of breast cancer is high, but it may be modified by exogenous and endogenous factors. There is concern that exposure to carcinogens in cigarette smoke may increase the risk of cancer in mutation carriers. We conducted a matched case-control study of 2,538 cases of breast cancer among women with a BRCA1 (n = 1,920) or a BRCA2 (n = 618) mutation. One non-affected mutation carrier control was selected for each case, matched on mutation, country of birth, and year of birth. Odds ratios were calculated using conditional logistic regression, adjusted for oral contraceptive use and parity. Ever-smoking was not associated with an increased breast cancer risk among BRCA1 carriers (OR = 1.09; 95% CI 0.95-1.24) or among BRCA2 carriers (OR = 0.81; 95% CI 0.63-1.05). The result did not differ when cases were restricted to women who completed the questionnaire within two years of diagnosis. A modest, but significant increase in risk was seen among BRCA1 carriers with a past history of smoking (OR = 1.27; 95% CI 1.06-1.50), but not among current smokers (OR = 0.95; 0.81-1.12). There appears to be no increase in the risk of breast cancer associated with current smoking in BRCA1 or BRCA2 carriers. There is a possibility of an increased risk of breast cancer among BRCA1 carriers associated with past smoking. There may be different effects of carcinogens in BRCA mutation carriers, depending upon the timing of exposure.

Original languageEnglish
Pages (from-to)127-135
Number of pages9
JournalBreast Cancer Research and Treatment
Volume114
Issue number1
DOIs
StatePublished - Mar 2009

Fingerprint

Smoking
Breast Neoplasms
Mutation
Carcinogens
Parturition
Oral Contraceptives
Parity
Smoke
Tobacco Products
Case-Control Studies
Logistic Models
Odds Ratio
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Ginsburg, O., Ghadirian, P., Lubinski, J., Cybulski, C., Lynch, H. T., Neuhausen, S., ... Narod, S. A. (2009). Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: An update. Breast Cancer Research and Treatment, 114(1), 127-135. https://doi.org/10.1007/s10549-008-9977-5

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers : An update. / Ginsburg, Ophira; Ghadirian, Parviz; Lubinski, Jan; Cybulski, Cezary; Lynch, Henry T.; Neuhausen, Susan; Kim-Sing, Charmaine; Robson, Mark; Domchek, Susan; Isaacs, Claudine; Klijn, Jan; Armel, Susan; Foulkes, William D.; Tung, Nadine; Moller, Pal; Sun, Ping; Narod, Steven A.

In: Breast Cancer Research and Treatment, Vol. 114, No. 1, 03.2009, p. 127-135.

Research output: Contribution to journalArticle

Ginsburg, O, Ghadirian, P, Lubinski, J, Cybulski, C, Lynch, HT, Neuhausen, S, Kim-Sing, C, Robson, M, Domchek, S, Isaacs, C, Klijn, J, Armel, S, Foulkes, WD, Tung, N, Moller, P, Sun, P & Narod, SA 2009, 'Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: An update', Breast Cancer Research and Treatment, vol. 114, no. 1, pp. 127-135. https://doi.org/10.1007/s10549-008-9977-5
Ginsburg, Ophira ; Ghadirian, Parviz ; Lubinski, Jan ; Cybulski, Cezary ; Lynch, Henry T. ; Neuhausen, Susan ; Kim-Sing, Charmaine ; Robson, Mark ; Domchek, Susan ; Isaacs, Claudine ; Klijn, Jan ; Armel, Susan ; Foulkes, William D. ; Tung, Nadine ; Moller, Pal ; Sun, Ping ; Narod, Steven A. / Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers : An update. In: Breast Cancer Research and Treatment. 2009 ; Vol. 114, No. 1. pp. 127-135.
@article{a29f1b3e4fc44a118c3502ff4bf9ec45,
title = "Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: An update",
abstract = "Among women with a mutation in BRCA1 or BRCA2, the risk of breast cancer is high, but it may be modified by exogenous and endogenous factors. There is concern that exposure to carcinogens in cigarette smoke may increase the risk of cancer in mutation carriers. We conducted a matched case-control study of 2,538 cases of breast cancer among women with a BRCA1 (n = 1,920) or a BRCA2 (n = 618) mutation. One non-affected mutation carrier control was selected for each case, matched on mutation, country of birth, and year of birth. Odds ratios were calculated using conditional logistic regression, adjusted for oral contraceptive use and parity. Ever-smoking was not associated with an increased breast cancer risk among BRCA1 carriers (OR = 1.09; 95{\%} CI 0.95-1.24) or among BRCA2 carriers (OR = 0.81; 95{\%} CI 0.63-1.05). The result did not differ when cases were restricted to women who completed the questionnaire within two years of diagnosis. A modest, but significant increase in risk was seen among BRCA1 carriers with a past history of smoking (OR = 1.27; 95{\%} CI 1.06-1.50), but not among current smokers (OR = 0.95; 0.81-1.12). There appears to be no increase in the risk of breast cancer associated with current smoking in BRCA1 or BRCA2 carriers. There is a possibility of an increased risk of breast cancer among BRCA1 carriers associated with past smoking. There may be different effects of carcinogens in BRCA mutation carriers, depending upon the timing of exposure.",
author = "Ophira Ginsburg and Parviz Ghadirian and Jan Lubinski and Cezary Cybulski and Lynch, {Henry T.} and Susan Neuhausen and Charmaine Kim-Sing and Mark Robson and Susan Domchek and Claudine Isaacs and Jan Klijn and Susan Armel and Foulkes, {William D.} and Nadine Tung and Pal Moller and Ping Sun and Narod, {Steven A.}",
year = "2009",
month = "3",
doi = "10.1007/s10549-008-9977-5",
language = "English",
volume = "114",
pages = "127--135",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers

T2 - An update

AU - Ginsburg, Ophira

AU - Ghadirian, Parviz

AU - Lubinski, Jan

AU - Cybulski, Cezary

AU - Lynch, Henry T.

AU - Neuhausen, Susan

AU - Kim-Sing, Charmaine

AU - Robson, Mark

AU - Domchek, Susan

AU - Isaacs, Claudine

AU - Klijn, Jan

AU - Armel, Susan

AU - Foulkes, William D.

AU - Tung, Nadine

AU - Moller, Pal

AU - Sun, Ping

AU - Narod, Steven A.

PY - 2009/3

Y1 - 2009/3

N2 - Among women with a mutation in BRCA1 or BRCA2, the risk of breast cancer is high, but it may be modified by exogenous and endogenous factors. There is concern that exposure to carcinogens in cigarette smoke may increase the risk of cancer in mutation carriers. We conducted a matched case-control study of 2,538 cases of breast cancer among women with a BRCA1 (n = 1,920) or a BRCA2 (n = 618) mutation. One non-affected mutation carrier control was selected for each case, matched on mutation, country of birth, and year of birth. Odds ratios were calculated using conditional logistic regression, adjusted for oral contraceptive use and parity. Ever-smoking was not associated with an increased breast cancer risk among BRCA1 carriers (OR = 1.09; 95% CI 0.95-1.24) or among BRCA2 carriers (OR = 0.81; 95% CI 0.63-1.05). The result did not differ when cases were restricted to women who completed the questionnaire within two years of diagnosis. A modest, but significant increase in risk was seen among BRCA1 carriers with a past history of smoking (OR = 1.27; 95% CI 1.06-1.50), but not among current smokers (OR = 0.95; 0.81-1.12). There appears to be no increase in the risk of breast cancer associated with current smoking in BRCA1 or BRCA2 carriers. There is a possibility of an increased risk of breast cancer among BRCA1 carriers associated with past smoking. There may be different effects of carcinogens in BRCA mutation carriers, depending upon the timing of exposure.

AB - Among women with a mutation in BRCA1 or BRCA2, the risk of breast cancer is high, but it may be modified by exogenous and endogenous factors. There is concern that exposure to carcinogens in cigarette smoke may increase the risk of cancer in mutation carriers. We conducted a matched case-control study of 2,538 cases of breast cancer among women with a BRCA1 (n = 1,920) or a BRCA2 (n = 618) mutation. One non-affected mutation carrier control was selected for each case, matched on mutation, country of birth, and year of birth. Odds ratios were calculated using conditional logistic regression, adjusted for oral contraceptive use and parity. Ever-smoking was not associated with an increased breast cancer risk among BRCA1 carriers (OR = 1.09; 95% CI 0.95-1.24) or among BRCA2 carriers (OR = 0.81; 95% CI 0.63-1.05). The result did not differ when cases were restricted to women who completed the questionnaire within two years of diagnosis. A modest, but significant increase in risk was seen among BRCA1 carriers with a past history of smoking (OR = 1.27; 95% CI 1.06-1.50), but not among current smokers (OR = 0.95; 0.81-1.12). There appears to be no increase in the risk of breast cancer associated with current smoking in BRCA1 or BRCA2 carriers. There is a possibility of an increased risk of breast cancer among BRCA1 carriers associated with past smoking. There may be different effects of carcinogens in BRCA mutation carriers, depending upon the timing of exposure.

UR - http://www.scopus.com/inward/record.url?scp=58849102634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849102634&partnerID=8YFLogxK

U2 - 10.1007/s10549-008-9977-5

DO - 10.1007/s10549-008-9977-5

M3 - Article

VL - 114

SP - 127

EP - 135

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -